#
Vizimpro
  • Treatments
  • Non-Small Cell Lung Cancer

Vizimpro

Generic name:dacomitinibDAK-oh-MI-ti-nib ]
Drug classes:EGFR inhibitors, HER2 inhibitors

Medically reviewed by Philip Thornton, DipPharm. Last updated on Jul 2, 2021.

What is Vizimpro?

Vizimpro is a prescription medicine used to treat non-small cell lung cancer that has spread to other parts of the body (metastasised).

Vizimpro is given only if your tumor has a specific genetic marker (an abnormal "EGFR" gene).

It is not known if Vizimpro is safe and effective in children.

Warnings

Follow all directions on your medicine label and package. Tell each of your healthcare providers about all your medical conditions, allergies, and all medicines you use.

Before taking this medicine

You may need to have a negative pregnancy test before starting this treatment.

Do not use Vizimpro if you are pregnant.Dacomitinib could harm the unborn baby. Use effective birth control to prevent pregnancy while you are using this medicine and for at least 17 days after your last dose. Tell your doctor if you become pregnant.

Do not breast-feed while using this medicine, and for at least 17 days after your last dose.

To make sure Vizimprois safe for you, tell your doctor if you have ever had:

  • frequent diarrhea; or

  • breathing problems (other than lung cancer).

How should I take Vizimpro?

Take Vizimpro exactly as prescribed by your doctor. Your doctor will perform a special test to make sure you have the correct tumor type to be treated with dacomitinib.

Follow all directions on your prescription label and read all medication guides or instruction sheets. Your doctor may occasionally change ...